Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Zymeworks Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Campoy Carlos (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 50,000 options to buy
@ $8.64, valued at
$432k
|
|
| 06/30/2023 |
3
| Campoy Carlos (Director) has filed a Form 3 on Zymeworks Inc. |
| 03/14/2023 |
4
| Klompas Neil A (President & COO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Exercised 2,708 restricted stock units
@ $0
Sold 2,977 shares
@ $7.8259, valued at
$23.3k
Exercised 2,500 restricted stock units
@ $0 |
|
| 01/23/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 144,100 shares
@ $9.4909, valued at
$1.4M
Bought 163,400 shares
@ $9.8843, valued at
$1.6M
|
|
| 01/18/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 342,100 shares
@ $9.806, valued at
$3.4M
Bought 440,000 shares
@ $9.8042, valued at
$4.3M
Bought 203,000 shares
@ $9.9953, valued at
$2M
|
|
| 01/12/2023 |
4
| EcoR1 Capital, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 920,000 shares
@ $7.6491, valued at
$7M
Bought 106,300 shares
@ $7.8731, valued at
$836.9k
|
|
| 01/06/2023 |
4
| Klompas Neil A (President & COO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 87,500 options to buy
@ $8, valued at
$700k
Granted 58,500 restricted stock units
@ $0 |
|
| 01/06/2023 |
4
| Astle Christopher (SVP & CFO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 47,000 options to buy
@ $8, valued at
$376k
Granted 31,500 restricted stock units
@ $0 |
|
| 01/06/2023 |
4
| Galbraith Kenneth (Chair & CEO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 215,000 options to buy
@ $8, valued at
$1.7M
Granted 143,000 restricted stock units
@ $0 |
|
| 01/06/2023 |
4
| Moore Paul Andrew (Chief Scientific Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 77,500 options to buy
@ $8, valued at
$620k
Granted 51,500 restricted stock units
@ $0 |
|
| 12/14/2022 |
4
| Astle Christopher (SVP & CFO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Sold 887 shares
@ $6.01, valued at
$5.3k
Exercised 1,550 restricted stock units
@ $0 |
|
| 11/14/2022 |
4
| Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Sold 2,475 shares
@ $8.099, valued at
$20k
Exercised 5,885 restricted stock units
@ $0 |
|
| 10/18/2022 |
4/A
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 30,481 shares
@ $5.0338, valued at
$153.4k
|
|
| 10/17/2022 |
4
| Redmile Group, LLC (10% Owner) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 30,481 shares
@ $5.0338, valued at
$153.4k
|
|
| 10/17/2022 |
3
| Redmile Group, LLC (10% Owner) has filed a Form 3 on Zymeworks Inc. |
| 10/17/2022 |
3
| Redmile Group, LLC (10% Owner) has filed a Form 3 on Zymeworks Inc. |
|
|